David Romano

1.4k total citations
22 papers, 1.1k citations indexed

About

David Romano is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, David Romano has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cell Biology and 7 papers in Oncology. Recurrent topics in David Romano's work include Hippo pathway signaling and YAP/TAZ (10 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). David Romano is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (10 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). David Romano collaborates with scholars based in Ireland, United Kingdom and France. David Romano's co-authors include Walter Kölch, David Matallanas, Eric O’Neill, Jens Rauch, Natalia Volinsky, J. Keith Vass, Daniela Piazzolla, Katrin Meissl, Manuela Baccarini and Lucia Kučerová and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

David Romano

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Romano Ireland 15 750 544 217 110 70 22 1.1k
Erik Wilker United States 16 1.1k 1.5× 270 0.5× 268 1.2× 67 0.6× 95 1.4× 24 1.5k
Shane Minogue United Kingdom 24 1.1k 1.5× 660 1.2× 166 0.8× 103 0.9× 120 1.7× 36 1.6k
Ursula Vogel United States 15 1.2k 1.6× 320 0.6× 306 1.4× 68 0.6× 72 1.0× 20 1.5k
Erik Kupperman United States 12 927 1.2× 251 0.5× 319 1.5× 58 0.5× 55 0.8× 17 1.2k
Angelique W. Whitehurst United States 23 1.4k 1.9× 296 0.5× 343 1.6× 87 0.8× 238 3.4× 36 1.8k
Michal Grzmil Switzerland 20 834 1.1× 159 0.3× 144 0.7× 68 0.6× 187 2.7× 32 1.2k
Roberta Fiume Italy 28 1.1k 1.4× 459 0.8× 118 0.5× 56 0.5× 102 1.5× 54 1.4k
Daniel T. Dransfield United States 18 780 1.0× 195 0.4× 283 1.3× 36 0.3× 223 3.2× 46 1.2k
Steven M. Riddle United States 14 858 1.1× 145 0.3× 254 1.2× 121 1.1× 63 0.9× 19 1.1k

Countries citing papers authored by David Romano

Since Specialization
Citations

This map shows the geographic impact of David Romano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Romano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Romano more than expected).

Fields of papers citing papers by David Romano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Romano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Romano. The network helps show where David Romano may publish in the future.

Co-authorship network of co-authors of David Romano

This figure shows the co-authorship network connecting the top 25 collaborators of David Romano. A scholar is included among the top collaborators of David Romano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Romano. David Romano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romano, David, Lucia García-Gutiérrez, David J. Duffy, et al.. (2022). Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma. Life Science Alliance. 5(10). e202201445–e202201445. 5 indexed citations
2.
Gérard, Corinne, Flora Poizat, Sandrine Oziel-Taïeb, et al.. (2020). Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms. Endocrine Related Cancer. 28(1). 39–51. 2 indexed citations
3.
Romano, David. (2019). Relevance of neuroendocrine tumours models assessed by kinomic profiling. Annales d Endocrinologie. 80(3). 144–148.
4.
5.
Rauch, Nora, Mohamed Ali Jarboui, Armin Zebisch, et al.. (2016). Autophosphorylation on S614 inhibits the activity and the transforming potential of BRAF. Cellular Signalling. 28(9). 1432–1439. 5 indexed citations
6.
Sánchez‐Sanz, Goar, David Matallanas, David Romano, et al.. (2016). SARAH Domain-Mediated MST2-RASSF Dimeric Interactions. PLoS Computational Biology. 12(10). e1005051–e1005051. 14 indexed citations
7.
Graillon, Thomas, David Romano, Céline Defilles, et al.. (2016). Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review. Journal of neurosurgery. 127(3). 660–669. 46 indexed citations
8.
Nguyen, Lan K., David Matallanas, David Romano, Boris Ν. Kholodenko, & Walter Kölch. (2015). Competing to coordinate cell fate decisions: the MST2-Raf-1 signaling device. Cell Cycle. 14(2). 189–199. 24 indexed citations
9.
Romano, David, Ana Herrero, Maria Luisa Guerriero, et al.. (2015). Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation. PLoS ONE. 10(6). e0129859–e0129859. 9 indexed citations
10.
Romano, David, Lan K. Nguyen, David Matallanas, et al.. (2014). Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling. Nature Cell Biology. 16(7). 673–684. 116 indexed citations
11.
Romano, David, David Matallanas, Dennie T. Frederick, Keith T. Flaherty, & Walter Kölch. (2014). One Hippo and many masters: differential regulation of the Hippo pathway in cancer. Biochemical Society Transactions. 42(4). 816–821. 12 indexed citations
12.
Romano, David, et al.. (2013). The Differential Effects of Wild-Type and Mutated K-Ras on MST2 Signaling Are Determined by K-Ras Activation Kinetics. Molecular and Cellular Biology. 33(9). 1859–1868. 27 indexed citations
13.
Rauch, Jens, Natalia Volinsky, David Romano, & Walter Kölch. (2011). The secret life of kinases: functions beyond catalysis. Cell Communication and Signaling. 9(1). 23–23. 153 indexed citations
14.
Matallanas, David, David Romano, Fahd Al‐Mulla, et al.. (2011). Mutant K-Ras Activation of the Proapoptotic MST2 Pathway Is Antagonized by Wild-Type K-Ras. Molecular Cell. 44(6). 893–906. 108 indexed citations
15.
Xu, Tian‐Rui, Ruifang Lu, David Romano, et al.. (2011). Eukaryotic Translation Initiation Factor 3, Subunit a, Regulates the Extracellular Signal-Regulated Kinase Pathway. Molecular and Cellular Biology. 32(1). 88–95. 33 indexed citations
16.
Romano, David, David Matallanas, Gregory Weitsman, et al.. (2010). Proapoptotic Kinase MST2 Coordinates Signaling Crosstalk between RASSF1A, Raf-1, and Akt. Cancer Research. 70(3). 1195–1203. 81 indexed citations
17.
Matallanas, David, David Romano, Garth Hamilton, Walter Kölch, & Eric O’Neill. (2008). A Hippo in the ointment: MST signalling beyond the fly. Cell Cycle. 7(7). 879–884. 32 indexed citations
18.
Matallanas, David, David Romano, Karen S. Yee, et al.. (2007). RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor Protein. Molecular Cell. 27(6). 962–975. 331 indexed citations
19.
Romano, David, Morgane Pertuit, Ramahefarizo Rasolonjanahary, et al.. (2006). Regulation of the RAP1/RAF-1/Extracellularly Regulated Kinase-1/2 Cascade and Prolactin Release by the Phosphoinositide 3-Kinase/AKT Pathway in Pituitary Cells. Endocrinology. 147(12). 6036–6045. 32 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Wilker Breakdown of academic impact, for papers by Shane Minogue Breakdown of academic impact, for papers by Ursula Vogel Breakdown of academic impact, for papers by Erik Kupperman Breakdown of academic impact, for papers by Angelique W. Whitehurst Breakdown of academic impact, for papers by Michal Grzmil Breakdown of academic impact, for papers by Roberta Fiume Breakdown of academic impact, for papers by Daniel T. Dransfield Breakdown of academic impact, for papers by Steven M. Riddle
Rankless by CCL
2026